From Nasdaq: 2025-01-18 15:00:00

Validea’s guru fundamental report for TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) (TEVA) shows it rates highest using the Twin Momentum Investor model. TEVA is a large-cap growth stock in the Biotechnology & Drugs industry, with a rating of 94% based on fundamental and valuation factors. Dashan Huang’s momentum model combines fundamental and price momentum, with TEVA scoring well on both. Huang, an Assistant Professor of Finance, identified seven fundamental variables that contribute to market outperformance. When combined with price momentum, TEVA shows strong interest and potential for outperformance. Validea offers investment research services based on strategies of investment legends like Warren Buffett and Benjamin Graham.



Read more at Nasdaq: TEVA Quantitative Stock Analysis | Nasdaq